CU6 1.17% $5.09 clarity pharmaceuticals ltd

Ann: First patient treated in theranostic prostate cancer trial, page-14

  1. 8 Posts.
    lightbulb Created with Sketch. 2
    The issues with return the next day, is that you are shedding radioactivity via body fluids.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.